| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |